Example: Heart Attack

Search clinical trials for: Sevelamer

Total 91 results

NCT01543958

Completed

Sevelamer for Reducing Endotoxemia and Immune Activation

Conditions: HIV-1 Infection
NCT01238588

Terminated

The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan

Conditions: Dialysis; Cardiovascular Disease; Atherosclerosis; Inflammation; Hyperphosphatemia
NCT00745589

Completed

Sevelamer Hydrochloride in Peritoneal Dialysis Patients

Conditions: Endstage Renal Disease
NCT03596749

Unknown status

The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4

Conditions: CKD Stage 3b; CKD Stage 4
NCT01574326

Completed

An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease

Conditions: Hyperphosphatemia; Chronic Kidney Disease
NCT01191762

Completed

Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease

Conditions: Hyperparathyroidism; Chronic Kidney Disease
NCT02332811

Completed

An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients

Conditions: Renal Failure Chronic
NCT00806481

Completed

Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease

Conditions: Kidney Failure, Chronic; Cardiovascular Diseases
NCT01427907

Completed

Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients

Conditions: Chronic Kidney Disease
NCT01736150

Completed

Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis

Conditions: Chronic Kidney Disease; Chronic Kidney Disease on Hemodialysis
NCT00833768

Terminated

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis

Conditions: Chronic Kidney Disease; Hyperphosphatemia
NCT03988920

Active, not recruiting

A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis

Conditions: Hyperphosphatemia; End Stage Renal Disease
NCT00837655

Withdrawn

Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)

Conditions: Kidney Failure, Chronic; End-Stage Renal Disease; Insulin Resistance; Hyperphosphatemia
NCT03305471

Completed

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Conditions: Hyperphosphatemia
NCT03644264

Completed

PA21 Safety and Efficacy in Adult Chinese Subjects

Conditions: Chronic Kidney Disease Requiring Chronic Dialysis; Hyperphosphatemia
NCT01135615

Completed

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

Conditions: We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.
NCT03001011

Completed

Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China

Conditions: Hyperphosphatemia
NCT01220843

Completed

FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease

Conditions: Chronic Renal Failure
NCT01968759

Completed

Sevelamer in Proteinuric CKD

Conditions: Chronic Kidney Disease
NCT01755078

Completed

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

Conditions: Hemodialysis; Hyperphosphatemia; Cardiovascular Events
NCT00681941

Completed

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

Conditions: Chronic Kidney Disease; Hyperphosphatemia
NCT03739268

Active, not recruiting

GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration

Conditions: Type 2 Diabetes Mellitus
NCT03451019

Completed

Different Effects of Non-calcium Phosphate Binders on Serum Calcium

Conditions: Chronic Kidney Disease
NCT00967629

Completed

Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy

Conditions: Diabetic Nephropathy
NCT00268957

Completed

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Conditions: Kidney Diseases; Chronic Renal Insufficiency; End-Stage Renal Disease